Core Viewpoint - Treace Medical Concepts, Inc. is facing a class action lawsuit due to alleged misleading statements and failure to disclose critical information regarding its business performance and product demand during the specified class period [3]. Group 1: Lawsuit Details - The class action lawsuit represents investors who purchased Treace Medical securities between May 8, 2023, and May 7, 2024 [1]. - Investors have until June 10, 2025, to file a lead plaintiff motion [1]. - The lawsuit claims that increased competition negatively impacted the demand for Treace Medical's core product, the Lapiplasty® 3D Bunion Correction System [3]. Group 2: Financial Impact - As a result of the competition, Treace Medical experienced a decline in revenue and was forced to expedite the development of an alternative product to osteotomy [3]. - The lawsuit alleges that the defendants made materially misleading representations about Treace Medical's business operations and future prospects, leading to investor damages when the true facts emerged [3]. Group 3: Legal Support - The Portnoy Law Firm offers complimentary case evaluations for investors seeking to recover losses and provides options for pursuing claims [2][4]. - The firm's founding partner has successfully recovered over $5.5 billion for aggrieved investors in the past [4].
Treace Medical Concepts, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 10, 2025 Deadline to file Lead Plaintiff Motion.